CGMP/Finished Pharmaceuticals/Adulterated
Similar Posts
Streamlined Trials Embedded in clinical Practice (STEP) Demonstration Project
C3TI aims to promote the adoption of pragmatic design in clinical trials and improve coordination and collaboration between CDER and sponsors to effectively support these innovative trials.Purity Products Announces Recall on the Dietary Supplement, My Bladder Because of Possible Health Risk
Plainview, NY. October 27, 2025— Purity Products is announcing a recall of one lot of of its dietary supplement MyBladder because it has the potential to be contaminated with Escherichia coli O7:K1 and 1303. The presence of these E. coli strains may pose a risk for gastrointestinal or other infectioFDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.Erosive Esophagitis: Developing Drugs for Treatment
Erosive Esophagitis: Developing Drugs for TreatmentHealwell Homeo Private Limited – 706206 – 06/12/2025
CGMP/Finished Pharmaceuticals/AdulteratedJuly 18, 2025: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement – 07/18/2025
July 18, 2025: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement